Evidence map›Paper›PMID 40497175›Full record

ArticleCureus2025

Reversible Cardiomyopathy in Polyarteritis Nodosa: A Case Report.

Rafik Issa, Michael Rudy

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rafik IssaDepartment of Internal Medicine, University of Michigan, Ann Arbor, USA.
Michael RudyDepartment of Internal Medicine, University of Michigan, Ann Arbor, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyarteritis nodosa (PAN) is a rare vasculitis that affects the medium-sized arteries, often involving numerous organ systems, including the heart. In this report, we present a case of a 26-year-old male with a two-month history of systemic symptoms, abdominal pain, and intrinsic acute kidney injury, who ultimately developed acute hypoxic respiratory failure secondary to acute pulmonary edema. His echocardiogram was notable for biventricular systolic dysfunction with reduced ejection fraction and regional wall motion abnormalities, but no coronary angiogram was pursued. His cardiac magnetic resonance imaging (MRI) study did not demonstrate evidence of myocarditis per Lake Louise criteria. Renal biopsy was consistent with medium-vessel vasculitis, confirming the diagnosis of PAN. He was initiated on immunosuppression with methylprednisolone and cyclophosphamide, and subsequently placed on guideline-directed medical therapy (GDMT) with metoprolol, sacubitril-valsartan, and dapagliflozin. At one-year follow-up, his symptoms had resolved, and his ejection fraction had normalized. Our case uniquely describes a cardiomyopathy phenotype that was likely stress-mediated in the context of active inflammation and was reversible with immunosuppression and GDMT, without the need for revascularization.

Indexed as

hfrefmyocarditispolyarteritis nodosastress cardiomyopathyvasculitis

Identifiers

PMID40497175
PMCPMC12149472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.